Entera Bio Ltd. WT EXP 062723 ENTXW

$ 0.0 0.0%

Quarterly report 2024-Q3
added 12-21-2024

Entera Bio Ltd. WT EXP 062723 Balance Sheet 2011-2024 | ENTXW

Annual Balance Sheet Entera Bio Ltd. WT EXP 062723

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-24.6 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt	256 K	-	123 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	134 K	91 K	179 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	288 K	32 K	261 K	371 K	-	-	-	-	-	-	-	-	-
Total Current Liabilities	1.09 M	1.34 M	3.16 M	1.84 M	-	-	-	-	-	-	-	-	-
Total Liabilities	1.38 M	1.37 M	3.42 M	2.21 M	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	15 K	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-104 M	-95.5 M	-82.4 M	-70.2 M	-	-	-	-	-	-	-	-	-
Total Assets	11.8 M	13.1 M	26 M	9.72 M	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	11 M	12.3 M	24.9 M	8.66 M	-	-	-	-	-	-	-	-	-
Book Value	10.4 M	11.8 M	22.6 M	7.51 M	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	10.4 M	11.8 M	22.6 M	7.51 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Entera Bio Ltd. WT EXP 062723

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	147 K	179 K	-	256 K	271 K	316 K	-	-	3 K	5 K	98 K	123 K	-	-	-	243 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	178 K	209 K	255 K	288 K	302 K	348 K	32 K	32 K	35 K	127 K	233 K	261 K	-	-	-	371 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1.29 M	1.5 M	1.38 M	1.38 M	2.33 M	2.21 M	1.53 M	1.37 M	1.23 M	1.82 M	2.57 M	3.42 M	-	-	-	2.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	15 K	-	-	-	158 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-112 M	-109 M	-106 M	-104 M	-102 M	-100 M	-97.7 M	-95.5 M	-92.5 M	-89.4 M	-86.2 M	-82.4 M	-	-	-	-70.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	7.74 M	10 M	10.2 M	11.8 M	8.56 M	10.4 M	11.6 M	13.1 M	15.5 M	19.1 M	22.3 M	26 M	-	-	-	9.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	6.92 M	9.06 M	-	11 M	7.58 M	9.14 M	10.7 M	12.3 M	14.3 M	17.3 M	20.1 M	24.9 M	27.4 M	26.9 M	16.4 M	8.59 M	-	-	-	15.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	6.45 M	8.53 M	8.86 M	10.4 M	6.24 M	8.23 M	10.1 M	11.8 M	14.3 M	17.3 M	19.7 M	22.6 M	-	-	-	7.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	6.45 M	8.53 M	8.86 M	10.4 M	6.24 M	8.23 M	10.1 M	11.8 M	14.3 M	17.3 M	19.7 M	22.6 M	26.3 M	26.3 M	15.6 M	7.51 M	-	-	-	13.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency